ScreenerHero

CLCChristina Lake Cannabis Corp.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · christinalakecannabis.com
0.0250CAD0.00%Mkt Cap: 4.52M $P/E: —

Christina Lake Cannabis Corp., a license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada. It provides distilled and winterized oils; kief pr…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
MERCK Kommanditgesellschaft auf Aktien
$65.19BUSDP/E 23.7
TAK
Takeda Pharmaceutical Co. Ltd.
$58.06BUSD
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$43.98BUSDP/E 20.4
TEVA
Teva Pharmaceutical Industries Limited
$43.51BUSDP/E 62.2
ZOE
Zoetis Inc.
$29.89BUSDP/E 12.7
ZTS
Zoetis Inc.
$32.12BUSDP/E 12.7
UTHR
United Therapeutics Corporation
$22.01BUSDP/E 18.4
VTRS
Viatris, Inc.
$18.75BUSD
SOBI
Swedish Orphan Biovitrum AB
$15.34BUSDP/E 117.3
IPN
Ipsen S.A.
$14.67BUSDP/E 26.4
NBIX
Neurocrine Biosciences, Inc.
$15.51BUSDP/E 22.3
ELAN
Elanco Animal Health Incorporat
$11.98BUSD
RDY
Dr. Reddy's Laboratories Ltd
$10.15BUSDP/E 29.7
KRK
Krka, d. d.
$8.66BUSDP/E 19.0
ALKS
Alkermes plc
$8.11BUSDP/E 127.2
HIMS
Hims & Hers Health, Inc.
$7.88BUSD
LNTH
Lantheus Holdings Inc
$6.53BUSDP/E 23.9
AMRX
Amneal Pharmaceuticals, Inc. Class A
$6.24BUSDP/E 37.3
LQDA
Liquidia Corporation
$6.14BUSDP/E 49.0
KNSA
Kiniksa Pharmaceuticals, Ltd.
$6.08BUSDP/E 79.8

Key Statistics

Company
Market Cap4.52M $
Enterprise Value8.15M $
Revenue (TTM)9.64M $
Gross Profit3.19M $
Net Income (TTM)-2.18M $
Revenue/Share0.0386 USD
Last Price0.0250 CAD
Fiscal Year EndFeb 2026
MR QuarterMay 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA17104U1021
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-9.43
EV/Revenue0.85
P/S0.37
P/B0.54
EPS (TTM)-0.01
EPS (Forward)—
52W Range
0.02500% of range0.0500
52W High0.0500 CAD
52W Low0.0250 CAD
Profitability
Gross Margin32.74%
Oper. Margin6.36%
EBITDA Margin-8.97%
Profit Margin-22.37%
ROE-30.92%
ROA-14.70%
Growth
Revenue Growth-3.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF13.89K $
CapEx (TTM)1.17M $
FCF Margin-13.02%
FCF Yield-27.77%
Net Debt4.54M $
Net Debt/EBITDA-5.25
Balance Sheet
Debt/Equity0.89
Current Ratio1.33
Quick Ratio0.44
Book Value/Sh0.0370 CAD
Cash/Share0.0070 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.248.09M
Float136.29M
Insiders38.20%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Out.0.00%
Shares Short485
Short (prev mo.)285
Technical
SMA 500.0257 (-2.7%)
SMA 2000.0321 (-22.1%)
Beta-0.83
S&P 52W Chg18.16%
Avg Vol (30d)15.97K
Avg Vol (10d)17.74K
Technical Indicators
RSI (14)16.5
MACD-0.0007
MACD Signal-0.0009
MACD Hist.+0.0002
BB Upper0.0250 CAD
BB Middle0.0250 CAD
BB Lower0.0250 CAD
BB Width0.00%
ATR (14)0.0001 CAD
Vol Ratio (20d)0.00x